SCHEMBL6959225

SCHEMBL6959225

CC(C)C1CNCC(OCc2ccc3ccccc3c2)C1c1ccc(Cl)cc1

nearest known ligand 0.55

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
REN P00797 17/20 0.55
SLC6A2 P23975 3/20 0.44
SLC6A4 P31645 3/20 0.44
SLC6A3 Q01959 3/20 0.44
KCNH2 Q12809 2/20 0.44
HTR2A P28223 1/20 0.43
HTR2C P28335 1/20 0.43
HTR7 P34969 1/20 0.43
HTR2B P41595 1/20 0.43
HTR3A P46098 1/20 0.43
HTR4 Q13639 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7591012 0.99 REN (0.54) RENSLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL6043116 0.90 REN (0.54) RENSLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL6043664 0.84 REN (0.61) RENSLC6A2SLC6A4SLC6A3HTR2C
SCHEMBL6042922 0.82 REN (0.59) RENSLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL7076347 0.81 REN (0.51) REN
SCHEMBL6042189 0.79 REN (0.43) REN
SCHEMBL6954219 0.76 REN (0.60) RENSLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL6042395 0.76 REN (0.80) REN
Hydrochloric Acid SCHEMBL8207725 0.76 REN (0.59) RENSLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL6958296 0.75 REN (0.52) RENSLC6A2SLC6A4SLC6A3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1256326-C Novel 4- (oxoxyphenyl) -3-oxopiperidines for the treatment of cardiac and renal insufficiency HOFFMANN LA ROCHE (CH) 2006-05-17 CN disclosed
EP-0863875-B1 NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY HOFFMANN LA ROCHE (CH) 2003-06-04 EP disclosed
CN-1202152-A Novel 4- (oxoxyphenyl) -3-oxopiperidines for the treatment of cardiac and renal insufficiency HOFFMANN LA ROCHE (CH) 1998-12-16 CN disclosed